Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Bogen Inger Lise

18 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Clinical Trial 7 Depression 7 Safety 6 Receptor Pharmacology 6 Animal Study 5 Drug Interactions 5 Mechanism of Action 3 General 3 Pharmacology 3 Cancer Patients 3 Anxiety 2 Adverse Events 2

Journals

Journal of psychopharmacology (Oxford, England) 2 ACS chemical neuroscience 2 Healthcare 1 Journal of Analytical Toxicology 1 AJPM Focus 1 ACS Chemical Neuroscience 1 Psychedelic Medicine 1 General hospital psychiatry 1

Publication history

Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.Journal of psychopharmacology (Oxford, England) · 2026-08-25 Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intakeJournal of Analytical Toxicology · 2026-05-23 Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-05-01 Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18 Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.ACS chemical neuroscience · 2025-11-19 “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-25 Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.General hospital psychiatry · 2025-01-01 Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.Cancer · 2024-04-01 Psychedelic-like Activity of Norpsilocin Analogues.ACS chemical neuroscience · 2024-01-17 Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.Frontiers in psychiatry · 2024-01-01 Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01 Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.BJPsych open · 2023-07-25 History of the administration of psychedelics in France.Frontiers in psychology · 2023-01-01 The Role of Psychedelics and Counseling in Mental Health TreatmentJournal of Mental Health Counseling · 2020-10-01 Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.Journal of psychopharmacology (Oxford, England) · 2011-11-01 Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2003-01-01 Analysis of psilocybin and psilocin in psilocybe subcubensis Guzman by ion mobility spectrometry and gas chromatography-mass spectrometryJournal of Clinical Forensic Medicine · 1999-09-01

Author directory